Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

CCT245718, a dual FLT3/Aurora A inhibitor overcomes D835Y-mediated resistance to FLT3 inhibitors in acute myeloid leukaemia cells
Muhammad Usama Tariq, Muhammad Furqan, Hira Parveen, et al.
British Journal of Cancer (2021) Vol. 125, Iss. 7, pp. 966-974
Open Access | Times Cited: 12

Showing 12 citing articles:

Therapeutic strategies of dual-target small molecules to overcome drug resistance in cancer therapy
Jing Ye, Junhao Wu, Bo Liu
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1878, Iss. 3, pp. 188866-188866
Closed Access | Times Cited: 25
The molecular mechanisms behind activation of FLT3 in acute myeloid leukemia and resistance to therapy by selective inhibitors
Ran Friedman
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2021) Vol. 1877, Iss. 1, pp. 188666-188666
Open Access | Times Cited: 27
Therapeutic Targeting of FLT3 in Acute Myeloid Leukemia: Current Status and Novel Approaches
Melisa Tecik, Aysun Adan
OncoTargets and Therapy (2022) Vol. Volume 15, pp. 1449-1478
Open Access | Times Cited: 19
Synthesis and characterization of bis-amide SSE1917 as a microtubule-stabilizing anticancer agent
Sana Iqbal, Farhat Firdous, Muhammad Furqan, et al.
Bioorganic Chemistry (2024) Vol. 143, pp. 107094-107094
Closed Access | Times Cited: 3
Pharmacophore-based virtual screening, molecular docking, and molecular dynamics studies for the discovery of novel FLT3 inhibitors
Mebarka Ouassaf, Ossama Daouı, Sarfaraz Alam, et al.
Journal of Biomolecular Structure and Dynamics (2022) Vol. 41, Iss. 16, pp. 7712-7724
Closed Access | Times Cited: 17
Design, Synthesis, and Biological Evaluation of SSE1806, a Microtubule Destabilizer That Overcomes Multidrug Resistance
Farhat Firdous, Sharon Riaz, Muhammad Furqan, et al.
ACS Medicinal Chemistry Letters (2023) Vol. 14, Iss. 10, pp. 1369-1377
Open Access | Times Cited: 5
The multi-kinase inhibitor CG-806 exerts anti-cancer activity against acute myeloid leukemia by co-targeting FLT3, BTK, and aurora kinases
Guopan Yu, Weiguo Zhang, Mahesh Basyal, et al.
Leukemia & lymphoma/Leukemia and lymphoma (2024), pp. 1-16
Open Access | Times Cited: 1
Synthesis and Evaluation of Novel Carboxamides Capable of Causing Centrosome Declustering and Apoptosis in Breast Cancer Cells
Usama B. Farrukh, Aishah Bilal, Huda Zahid, et al.
ChemistrySelect (2022) Vol. 7, Iss. 15
Closed Access | Times Cited: 5
Computer-Aided Identification and Design of Ligands for Multi-Targeting Inhibition of a Molecular Acute Myeloid Leukemia Network
Seyedehsadaf Asfa, Reza Arshinchi Bonab, Onur Önder, et al.
Cancers (2024) Vol. 16, Iss. 21, pp. 3607-3607
Open Access
Synthesis and Characterization of Griseofulvin Derivatives as Microtubule‐Stabilizing Agents
Farhat Firdous, Rida Ibrahim, Muhammad Furqan, et al.
ChemistrySelect (2022) Vol. 7, Iss. 43
Closed Access | Times Cited: 3
Dual FLT3/haspin kinase inhibitor based on 3H-pyrazolo[4,3-f]quinoline scaffold with activities against acute myeloid leukemia
Allison L. Kempen, Nickolas R. Brauer, Herman O. Sintim
RSC Medicinal Chemistry (2023) Vol. 14, Iss. 9, pp. 1743-1754
Closed Access
Meet the Editorial Board Member
Rahman Shah Zaib Saleem
Current Nutraceuticals (2022) Vol. 3, Iss. 1
Closed Access
Page 1

Scroll to top